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Well validated techniques New techniques - need validation
Liver and spleen morphologic features
• qualitative and quantitative data
Hepatic vasculature morphology and patency
• qualitative and semi-quantitative data
Microvascular derangement
• dynamic quantitative data on hepatic transit time and perfusion by microbubbles,
kinetics digitally assessed
r stiffness estimation indirectly 




-mode visualization of the region of 
terest (ROI)
uantitative data
Elasticity/stiffness of the tissue
• ROI placed on direct B-mode 

















 Transient elastography (TE) Acoustic radiation force impulse 
imaging (ARFI)
ShearWave elastography (SWE)
Advantages • Reference standard to be beaten
• User-friendly (performed at bedside; 
rapid, short learning curve)
• Good reproducibility
• High range of values (2-75 kPa)
• Quality criteria well deﬁ ned
• High performance for cirrhosis 
(AUROC >0.9)
• Prognostic value in cirrhosis
• Can be implemented on a regular US 
machine
• ROI smaller than TE but chosen by 
the operator
• Higher applicability than TE (ascites 
and obesity)
• Performance likely equivalent to 
that of TE for signiﬁ cant ﬁ brosis and 
cirrhosis
• Can be implemented on a regular US 
machine
• ROI can be adjusted in size and 
location and chosen by the operator
• Measures liver stiffness in real-time
• High range of values (2-150 kPa)
• Good applicability
• Performance may be higher than TE 
for signiﬁ cant ﬁ brosis
Disadvantages • Requires a dedicated device
• Region of Interest (ROI) cannot be 
chosen
• Unable to discriminate between 
intermediate stages of ﬁ brosis
• Low applicability 80% (obesity, 
ascites, limited operator experience)
• False positive in case of acute 
hepatitis, extra-hepatic cholestasis 
• Ongoing validation
• Unable to discriminate between 
intermediate stages of ﬁ brosis
• Units (m/sec) different from that of 
TE (kPa)
• Narrow range of values 
(0.5-4.4 m/sec)
• Quality criteria not well deﬁ ned
• Inﬂ uence of inﬂ ammation?
ost
• Further validation warranted
• Unable to discriminate between 
intermediate stages of ﬁ brosis
• Limited data on reproducibility
• Learning curve?
• Quality criteria?
• Inﬂ uence of inﬂ ammation?
Table 1.  Respective advantages and disadvantages of currently available US-based techniques for measuring liver stiffness.Introduction
Staging of liver fibrosis is crucial in the management of patients with 
chronic liver diseases (CLD) since fibrosis severity influences the prog-
nosis and treatment options. An early diagnosis of cirrhosis is particu-
larly important in patients with compensated CLD, because it triggers 
screening for portal hypertension and hepatocellular carcinoma. Liver 
biopsy has been considered the reference technique for staging liver 
fibrosis, but has well known limitations, including invasiveness and 
sampling errors, which have led to explore non-invasive surrogates [1].
Ultrasound has been used for many years for the work-up of patients 
with CLD because of its ease of use and wide availability. Recent tech-
nological advances have allowed liver fibrosis staging using a variety of 
US-based techniques (Fig. 1).
US techniques to assess liver and spleen morphologic features
Ultrasound is inaccurate in detecting mild fibrosis. Indeed, liver mor-
phology is normal in patients with mild fibrosis, while significant liver 
fibrosis deposition progressively induces changes in liver (and spleen) 
anatomy, which can be characterized by conventional grey-scale B-
mode ultrasound (US). Among them, liver surface irregularity, heteroge-
neity of liver echotexture and increase in spleen size are often seen in 
patients with significant fibrosis and early cirrhosis, and left-to-right liver 
volume redistribution (left liver lobe and caudate lobe often increase in 
size in cirrhosis) can become evident in established cirrhosis [2]. Even 
if none of these signs are accurate enough for distinguishing mild to 
moderate/severe fibrosis, their combination improves the performance 
of US to detect cirrhosis, reaching an accuracy of over 80% [2]. A closer 
look to morphology can be obtained by the digital analysis of US images 
of the liver parenchyma (quantification of the heterogeneity of echotex-
ture, Acoustic Structure Quantification, Toshiba Medical Systems [3]) 
and congestion • Prognand of liver surface studied by high frequency ultrasound (nodularity 
quantification [4]).
Fig. 1. Update on ultrasound imaging of liver fibrosis. Morphologic features of the (A) liver and
are the mainstay of the US diagnosis of cirrhosis, but are inaccurate for discriminating mild to mod
structure quantification allow a digital analysis of the two most important US aspects related to fi
Changes in the anatomy of hepatic vessels can be studied by Colour- and Power-Doppler US (E a
has already developed. On the other hand, in pre-cirrhotic phases, when macrovasculature is norm
contrast-enhanced ultrasound techniques, such as hepatic transit time (interval occurring between
as liver fibrosis amount increases. Liver stiffness measurement has been indirectly evaluated by 
tracing on pulsed US-Doppler (I) with inaccurate results. Transient elastography (FibroScan®, Ech
and accurate for the quantitative, non-invasive measurement of liver fibrosis; a limitation of this 
measurement is done, since the machine only allows it in monodimensional (M)-mode. Newer pro
(Hitachi Medical Systems) (K), based on measurement of elastic strain ratio, and shear-wave elas
tion Force Impulse imaging (Acuson 2000 Virtual TouchTM Tissue Quantification, Siemens Healthc
Aix en Provence, France) (M).
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Liver fibrosis induces a progressive distortion of the intrahepatic vas-
culature and is accompanied by angiogenesis, concurring to portal 
hypertension in cirrhosis. Colour (CDUS) and Power Doppler US are 
accurate in assessing liver macrovascular anatomy and its changes 
secondary to portal hypertension [5], but no sign is observed before 
cirrhosis develops. Conversely, contrast-enhanced US (CEUS) allows 
the study of the microvascular component of hepatic circulation. The 
interval between the appearance of contrast microbubbles (purely intra-
vascular) in the portal vein (or hepatic artery) and hepatic veins, known 
as hepatic transit time (HTT), shortens progressively as liver fibrosis 
progresses [6], due to intrahepatic arteriovenous shunting and arteriali-
zation of the liver vasculature. Even if HTT accuracy in diagnosing mild
or moderate fibrosis remains unsatisfactory, preliminary data indicate a 
better performance in diagnosing cirrhosis. CEUS can also be used to 
assess regional hepatic perfusion, which correlates with the severity of 
liver failure and circulatory abnormalities in cirrhosis [5].
US techniques to estimate liver stiffness
Spectral analysis of hepatic blood flow tracings by Pulsed-Doppler US was
used in the 90s and early 2000s as surrogate measurement of liver and
spleen stiffness. Portal vein velocity decreases, hepatic and splenic artery
resistance and pulsatility index (PI) increase, and hepatic veins tracing flat-
tens, as fibrosis progresses and as portal pressure increases [5]. Splenic
artery PI has shown a good accuracy for the prediction of significant fi-
brosis (AUROC 0.87; diagnostic accuracy of 79% using 1.10 as cut-off 
value) and cirrhosis (AUROC 0.90; diagnostic accuracy of 90% using 1.40
as cut-off value) in HCV patients [7]. However, Doppler resistance varies
according to several factors unrelated to liver fibrosis, and its routine meas-
urement is not recommended [5].
   A major advance in the measurement of stiffness (or elasticity) was further 
ic value in cirrhosis?brought in by the development of liver elasticity-based US techniques. Their 
respective advantages and disadvantages are summarized in the Table 1.
 (B) spleen on grey-scale ultrasound can suggest the presence of significant fibrosis and 
erate/severe fibrosis. (C) High frequency ultrasound of the liver surface and (D) acoustic 
brosis deposition, namely irregularity of liver profile and heterogeneity of its echotexture. 
nd F) and are useful to depict the presence of signs of portal hypertension when cirrhosis 
al, changes in the hepatic microvasculature can already be found and can be studied by 
 the arrival of microbubbles in the portal vein and hepatic veins: G and H), which shortens 
calculating hepatic artery resistance and pulsatility index derived from blood flow velocity 
osens, Paris, France) (J) was the first technique assessing stiffness and is well validated 
technique depends on the lack of direct visualization of the region of interest where the
posed sonographic techniques overcoming this limitation include real-time elastography 
tography, which is already available on different ultrasound equipments: Acoustic Radia-
are, Erlangen, Germany) (L); shear-wave elastography (Aixplorer®, Supersonic Imagine, 
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  Monodimensional ultrasound transient elastography, (TE, FibroS-
can®, Echosens, Paris, France), was the first introduced technique in 
the early 2000s. Its principle relies on the measurement of the velocity 
of a low-frequency (50 Hz) elastic shear wave propagating through the 
liver, that is directly related to tissue stiffness, called the elastic modulus
(expressed as E = 3ρv2, where v is the shear velocity and ρ is the densi-
ty of tissue, assumed to be constant) [8]. The stiffer the tissue, the faster 
the shear wave propagates. TE measures liver stiffness in a volume 
that approximates a cylinder (10-mm wide, 40-mm long), 25–65 mm
below skin surface; this region is only visualized in M-mode. Its results 
are expressed in kilopascals (kPa), and range from 2.5 to 75 kPa, with 
normal value around 5 kPa. Accurate results require careful interpreta-
tion of data, based on at least 10 validated measurements, a success
rate (the ratio of valid measurements to the total number of measure-
ment) >60%, and an interquartile range (IQR, reflects variations among 
measurements) <30% of the median value (IQR/LSM ≤30%) [9]. TE is 
currently the most widely used and best validated technique for non-
invasive assessment of liver fibrosis worldwide, mainly in viral hepatitis 
[1]. Its diagnostic performance is better for cirrhosis than for significant 
fibrosis, with mean AUROC values of 0.94 and 0.84, respectively [10].
The main limitation of TE in clinical practice is its limited applicability 
(80%), mostly due to obesity, ascites or limited operator experience
[11]. Recently, the XL-probe has been proposed in order to increase the 
applicability of TE in obese subjects, but its validation is still ongoing. 
Also hepatic inflammation, extrahepatic cholestasis, or congestion can 
lead to overestimation of liver stiffness, independently of fibrosis [1].
  More recently, 2D-elastography techniques incorporated into conven-
tional US machines (sonoelastography), hence allowing the examiner 
visually choosing a region of interest in B-mode, have been introduced
and are currently under investigation.
  Real-time elastography (RTE, Hitachi Medical Systems) is based on 
strain imaging induced by slight manual compression; it is less accu-
rate in staging liver fibrosis than TE [12]. Other techniques are based 
on the measurement of the velocity of shear waves generated by me-
chanically exciting liver tissue by ultrasound pushes. The first one to be 
described was acoustic radiation force impulse imaging (ARFI, Acuson 
2000 Virtual TouchTM Tissue Quantification, Siemens Healthcare, Er-
langen, Germany). The shear-wave velocity is measured in a region 
of interest 6-mm wide, 10-mm long, and in contrast to TE, results are 
not expressed in kPa and have a narrower range (range: 0.5–4.4 m/
sec) that may represent a limitation for definition of clinically relevant 
cut-offs. ARFI applicability is high [13], and its accuracy is likely similar 
to that of TE (AUROC 0.87 for diagnosis of significant fibrosis and 0.93 
for cirrhosis) [14], but validation is still ongoing and its place remains 
to be defined in clinical practice. Sonoelastography techniques have 
the added advantage of improving the applicability of measurement of 
spleen stiffness, which is emerging as a novel non-invasive parameter 
closely correlating with portal pressure in cirrhosis [15].
  Shear-Wave elastography (SWE, Aixplorer®, Supersonic Imagine, Aix 
en Provence, France) has the advantage of being able to image liver 
stiffness in real time. Preliminary results suggest that SWE may have 
better performance than TE for diagnosing significant fibrosis in HCV 
patients [16], but further validation is warranted.
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